Cap displayed in your preferred currency (USD)
Industries & Sectors
| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| North America (Primary) | PRIMARYNOAM | Univ | 8,182 | 57,735,260 | 1.17% | 0.69% | -0.55% | 3.20% | 17.21% | 22.70% |
| Healthcare | HEALTHCARE | Sector | 1,343 | 6,388,469 | 0.29% | 1.41% | -0.56% | -1.12% | 15.27% | 9.49% |
| Biopharmaceuticals | BIOPHARMA | SubSec | 680 | 2,955,318 | 0.10% | 2.57% | -1.73% | -2.72% | 23.89% | 24.55% |
| System-Specific Biopharmaceuticals | BIOPHARMASYS | Industry | 308 | 1,511,979 | -0.59% | 2.10% | -2.46% | -2.28% | 20.73% | 10.62% |
| Digestive System Biopharmaceuticals | DIGESTIVE | SubInd | 30 | 28,522 | 3.75% | 9.41% | -1.09% | 21.81% | 66.65% | 6.94% |
Show Stocks
Sort: 1Mo %
| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| Ardelyx, Inc. | ARDX:USAARDX:USA | Stock | 1 | 2,040 | 28.42% | 35.83% | 21.79% | -2.68% | 117.46% | 85.53% |
| Wave Life Sciences Ltd. | WVE:USAWVE:USA | Stock | 1 | 732 | 4.42% | 31.76% | 4.96% | 58.66% | 15.41% | 68.22% |
| Viking Therapeutics, Inc. | VKTX:USAVKTX:USA | Stock | 1 | 8,484 | 1.60% | 3.58% | 4.47% | 212.12% | 687.01% | 255.19% |
| Mirum Pharmaceuticals, Inc. | MIRM:USAMIRM:USA | Stock | 1 | 1,207 | 0.94% | 5.64% | 2.01% | -1.64% | -8.98% | -7.22% |
| Spyre Therapeutics, Inc. | SYRE:USASYRE:USA | Stock | 1 | 1,290 | -1.35% | 6.62% | 1.13% | 41.37% | 210.86% | 794.50% |
| S&P 500 | SPY:USASPY:USA | Benchmark | 14,779 | 75,176,635 | 1.24% | 0.60% | -0.35% | 4.13% | 19.55% | 28.03% |
| Ironwood Pharmaceuticals, Inc. | IRWD:USAIRWD:USA | Stock | 1 | 1,270 | -2.17% | 3.84% | -0.37% | -44.95% | -9.68% | -23.25% |
| Morphic Holding, Inc. | MORF:USAMORF:USA | Stock | 1 | 1,498 | 4.14% | 6.52% | -0.70% | -16.90% | 43.34% | -43.38% |
| Digestive System Biopharmaceuticals | DIGESTIVE | SubInd | 30 | 28,522 | 3.75% | 9.41% | -1.09% | 21.81% | 66.65% | 6.94% |
| Madrigal Pharmaceuticals, Inc. | MDGL:USAMDGL:USA | Stock | 1 | 4,568 | 6.38% | 18.88% | -4.81% | 1.23% | 67.28% | -25.52% |
| Arrowhead Pharmaceuticals, Inc. | ARWR:USAARWR:USA | Stock | 1 | 2,627 | 1.28% | 10.49% | -6.40% | -23.67% | -6.57% | -38.98% |
| Phathom Pharmaceuticals, Inc. | PHAT:USAPHAT:USA | Stock | 1 | 582 | 2.87% | 9.37% | -7.04% | 50.30% | 25.81% | -14.19% |
| Akero Therapeutics, Inc. | AKRO:USAAKRO:USA | Stock | 1 | 1,096 | -0.25% | -0.41% | -14.41% | -2.87% | 47.60% | -56.07% |
| Verve Therapeutics, Inc. | VERV:USAVERV:USA | Stock | 1 | 525 | 4.23% | 4.06% | -26.15% | -40.70% | -53.98% | -60.70% |
* Colors indicate performance relative to the benchmark.